Alan Schatzberg
Affiliations: | Psychiatry | Stanford University, Palo Alto, CA |
Google:
"Alan Schatzberg"Mean distance: 14.12 (cluster 17)
Children
Sign in to add trainee| Eric Wexler | grad student | Stanford | |
| Keith D. Sudheimer | grad student | 2008-2020 | |
| Amit Etkin | post-doc | Stanford | |
| Adina S. Fischer | post-doc | Stanford | |
| Nolan R. Williams | research scientist | 2014- | Stanford |
| Lukas Pezawas | research scientist | 2015- | Stanford |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Watson KT, Keller J, Spiro CM, et al. (2024) Proteomic profiles of cytokines and chemokines in moderate to severe depression: Implications for comorbidities and biomarker discovery. Brain, Behavior, & Immunity - Health. 36: 100731 |
| Lii TR, Smith AE, Flohr JR, et al. (2023) Randomized trial of ketamine masked by surgical anesthesia in patients with depression. Nature Mental Health. 1: 876-886 |
| Vreijling SR, Chin Fatt CR, Williams LM, et al. (2023) Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials. The British Journal of Psychiatry : the Journal of Mental Science. 1-9 |
| McIntyre RS, Alsuwaidan M, Baune BT, et al. (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412 |
| Schatzberg AF, Mathew SJ. (2023) The why, when, where, how, and so what of so-called rapidly acting antidepressants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Hack LM, Tozzi L, Zenteno S, et al. (2023) A Cognitive Biotype of Depression and Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment Outcomes: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Jama Network Open. 6: e2318411 |
| Reich J, Schatzberg A. (2023) Childhood maladaptive coping mechanisms and the subsequent development of depression. Clinical Psychology & Psychotherapy |
| Schatzberg AF. (2022) An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression. The American Journal of Psychiatry. 179: 890-891 |
| Sforzini L, Worrell C, Kose M, et al. (2021) A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry |
| Cole EJ, Phillips AL, Bentzley BS, et al. (2021) Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial. The American Journal of Psychiatry. appiajp202120101429 |